Published: Guidance, quality standards and advice

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Last updated date

Last updated date

Area of interest

Area of interest

Type 1 selected

Type

Guidance programme

Showing 951 to 1000 of 1898

TitleReference numberPublishedLast updated
Guselkumab for treating moderate to severe plaque psoriasisTA521
Midostaurin for untreated acute myeloid leukaemiaTA523
Brentuximab vedotin for treating CD30-positive Hodgkin lymphomaTA524
Atezolizumab for treating locally advanced or metastatic urothelial carcinoma after platinum-containing chemotherapyTA525
Arsenic trioxide for treating acute promyelocytic leukaemiaTA526
Intranasal phototherapy for allergic rhinitisIPG616
Cancer of the upper aerodigestive tract: assessment and management in people aged 16 and overNG36
Endoscopic bipolar radiofrequency ablation for treating biliary obstruction caused by cancerIPG614
Low-level laser therapy for preventing or treating oral mucositis caused by radiotherapy or chemotherapyIPG615
Atezolizumab for treating locally advanced or metastatic non-small-cell lung cancer after chemotherapyTA520
Percutaneous balloon valvuloplasty for fetal critical aortic stenosisIPG613
Adjunctive colposcopy technologies for assessing suspected cervical abnormalities: the DYSIS colposcope with DYSISmap and the ZedScan IDG32
Robot-assisted kidney transplantIPG609
Prostate artery embolisation for lower urinary tract symptoms caused by benign prostatic hyperplasiaIPG611
Microinvasive subconjunctival insertion of a trans-scleral gelatin stent for primary open-angle glaucomaIPG612
Nerve transfer to partially restore upper limb function in tetraplegiaIPG610
Tocilizumab for treating giant cell arteritisTA518
Care and support of people growing older with learning disabilitiesNG96
Eribulin for treating locally advanced or metastatic breast cancer after 1 chemotherapy regimenTA515
Cabozantinib for treating medullary thyroid cancerTA516
Learning disabilities and behaviour that challenges: service design and deliveryNG93
Emergency and acute medical care in over 16s: service delivery and organisationNG94
Physical activity and the environmentNG90
Brodalumab for treating moderate to severe plaque psoriasisTA511
Tivozanib for treating advanced renal cell carcinomaTA512
Obinutuzumab for untreated advanced follicular lymphomaTA513
Mosaicplasty for symptomatic articular cartilage defects of the kneeIPG607
Laparoscopic mesh pectopexy for apical prolapse of the uterus or vaginaIPG608
Autologous chondrocyte implantation using chondrosphere for treating symptomatic articular cartilage defects of the kneeTA508
Pertuzumab with trastuzumab and docetaxel for treating HER2-positive breast cancerTA509
Unilateral MRI-guided focused ultrasound thalamotomy for moderate to severe tremor in Parkinson's diseaseIPG606
Sofosbuvir–velpatasvir–voxilaprevir for treating chronic hepatitis CTA507
People's experience in adult social care services: improving the experience of care and support for people using adult social care servicesNG86
Aortic valve reconstruction with processed bovine pericardiumIPG604
Raloxifene for the primary prevention of osteoporotic fragility fractures in postmenopausal womenTA160
Raloxifene and teriparatide for the secondary prevention of osteoporotic fragility fractures in postmenopausal womenTA161
Strimvelis for treating adenosine deaminase deficiency–severe combined immunodeficiencyHST7
Pancreatic cancer in adults: diagnosis and managementNG85
Pirfenidone for treating idiopathic pulmonary fibrosisTA504
Intrabeam radiotherapy system for adjuvant treatment of early breast cancerTA501
Ibrutinib for treating relapsed or refractory mantle cell lymphomaTA502
Fulvestrant for untreated locally advanced or metastatic oestrogen-receptor positive breast cancerTA503
Sore throat (acute): antimicrobial prescribingNG84
Lenvatinib with everolimus for previously treated advanced renal cell carcinomaTA498
Glecaprevir–pibrentasvir for treating chronic hepatitis CTA499
Ceritinib for untreated ALK-positive non-small-cell lung cancerTA500
Age-related macular degenerationNG82
Golimumab for treating non-radiographic axial spondyloarthritisTA497
Palbociclib with an aromatase inhibitor for previously untreated, hormone receptor-positive, HER2-negative, locally advanced or metastatic breast cancerTA495
Ribociclib with an aromatase inhibitor for previously untreated, hormone receptor-positive, HER2-negative, locally advanced or metastatic breast cancerTA496

Results per page

  1. 10
  2. 25
  3. 50
  4. All